| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Kishimoto Takashi Kei is a Chief Scientific Officer at Cartesian Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | RNAC Cartesian Therapeutics, Inc. | Chief Scientific Officer | Sell | 9,784 | $1.13 | $11,076.96 | -0.7% | +12.1% | -46.3% | |
| Jan 5, 2022 | RNAC Cartesian Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,416 | $3.09 | $10,541.43 | -1.3% | -56.3% | -61.6% | |
| Dec 10, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,370 | $2.99 | $13,052.75 | -2.1% | -41.9% | -58.8% | |
| Oct 13, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,892 | $4.39 | $17,085.88 | -2.0% | -35.4% | -63.4% | |
| Dec 28, 2016 | RNAC Cartesian Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 10,000 | $17.55 | $175,500.00 | -100% | - | - |